Related Experiment Video
Updated: Oct 6, 2025
05:40
Using an Automated Hirschberg Test App to Evaluate Ocular Alignment
Published on: March 24, 2020
12.9K
Pediatric apps: what are they for? A scoping review
Bruno José Nievas Soriano1, Juan Uribe-Toril2, José Luis Ruiz-Real3
1Nursing, Physiotherapy and Medicine Department, University of Almería, 04120, Almería, Spain.
European Journal of Pediatrics
|January 20, 2022
Summary
This review of pediatric health apps found they primarily support clinical decisions, patient education, and self-management for conditions like cancer, obesity, and asthma. Most apps targeted children and caregivers, with studies mainly using observational methods.
Area of Science:
- Digital Health
- Pediatric Health Technology
- Mobile Health (mHealth) Applications
Background:
- Digital health technologies are expanding healthcare's reach and improving pediatric health outcomes.
- Increasing smartphone access enables apps for delivering, promoting, and sustaining health interventions for children.
- A systematic review is needed to analyze peer-reviewed scientific literature on mHealth apps for children.
Purpose of the Study:
- To systematically review scientific literature on pediatric health apps.
- To identify the primary purpose, medical specialties, target audience, and analysis methods of these apps.
- To provide insights for future pediatric mHealth app development.
Main Methods:
- Systematic literature review following PRISMA methodology.
- Search conducted on Web of Science Core Collection using terms "pediatr*" and "app."
- Analysis of 116 selected peer-reviewed articles.
Main Results:
- Pediatric health apps primarily aim to support clinical decision-making, patient education, and self-management.
- Common topics include cancer, obesity, and asthma, with hematology-oncology and endocrinology as frequent specialties.
- Apps target children, caregivers, or both; most studies used observational designs, predominantly from the USA.
Conclusions:
- Pediatric health apps focus on education, decision support, and self-management for prevalent childhood conditions.
- Future development should consider the identified target audiences and common medical specialties.
- Further research may explore app development costs and diverse analytical approaches.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
11
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
12
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
10
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
17
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
01:29Drug Dosing: Infants and Children
21
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
191
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
191